Trial intelligence / Profile preview

Vascular Pleiotropic Effects of Bisphosphonates in Postmenopausal Women with Osteoporosis

2007-004529-57Phase 4Completed

Sponsor
Greenpark Health Care Trust
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of risedronate in osteoporosis, sponsored by Greenpark Health Care Trust. Primary endpoints: Platelet nitric oxide bioavailability and Platelet superoxide (O2-) production. Started Oct 2007; status: completed.

02

Drugs

risedronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on 2007-004529-57.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004529-57.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call